AngioDynamics: MedTech Growth of 26% - Specialist in Cancer and Vascular Diseases with New Buy Signal!

AngioDynamics (ANGO) focuses as a medical technology company on minimally invasive treatment solutions for cancer and peripheral vascular diseases. The rapidly growing MedTech segment increases the addressable market potential to $10 billion and was able to grow by 26.1% in the last quarter. This marks four consecutive quarters of segment growth exceeding 20%. In addition to Auryon, AngioVac, and AlphaVac, NanoKnife stands out as the only FDA-approved device for irreversible electroporation (IRE) for the treatment of prostate tissue. Targeted...